4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001628280-23-039192
Director sold 47,000 shares at $2.52 ($118,581)
- Director returned 27,117 shares (to the company)
- Director acquired 47,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hively Brad Director | 2023-11-13 | Option exercise | +47,000 | $0.85 | $39,950 | 771,182 | D |
| Hively Brad Director | 2023-11-13 | Sale | −47,000 | $2.52 | $118,581 | 724,182 | D |
| Hively Brad Director | 2023-11-14 | Returned to the company | −27,117 | $2.39 | $64,755 | 697,065 | D |
| Derivatives | |||||||
| Hively Brad Director | 2023-11-13 | Option exercise · Non-Qualified Stock Option (right to buy) | −47,000 | 1,770,431 | D | ||
| Open-market sales · 47,000 sh · avg $2.52 · $118,581 | |||||||
Loading xslF345X05/wk-form4_1700092157.xml…